Early administration of zoledronic acid after hip fracture
- PMID: 40042619
- DOI: 10.1007/s00198-025-07450-z
Early administration of zoledronic acid after hip fracture
Conflict of interest statement
Declarations. Conflict of interest: None.
References
-
- Malgo F, van Deudekom FJA, Hup R, Formijne Jonkers HA, Kempen DHR, de Vries K et al (2024) Inpatient zoledronic acid in older hip fracture patients is well tolerated and safe. Arch Osteoporos 19(1):96. https://doi.org/10.1007/s11657-024-01453-9 - DOI - PubMed
-
- Fan W, Sun X, Leder BZ, Lee H, Ly TV, Pu CT et al (2024) Zoledronic acid for hip fracture during initial hospitalization. J Bone Miner Res 39(8):1061–1070. https://doi.org/10.1093/jbmr/zjae101 - DOI - PubMed
-
- Conley RB, Adib G, Adler RA, Åkesson KE, Alexander IM et al (2020) Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition. J Bone Miner Res 35(1):36–52. https://doi.org/10.1002/jbmr.3877 - DOI - PubMed
-
- Mahon J (2022) Hip fractures in older Irish adults and treatment with zoledronic acid. J Mahon. Trinity College Dublin, School of Medicine. http://hdl.handle.net/2262/97934
-
- Bhujwalla S, Johansen A, Tham Y, Dockery F (2024) Exploring barriers to timely administration of intravenous zoledronic acid following hip fracture. Age Ageing 53(Supplement_4):afae178.246. https://doi.org/10.1093/ageing/afae178.246
Publication types
LinkOut - more resources
Full Text Sources
